Wednesday, January 24, 2018 3:59:59 PM
MariMed Closes $4 Million Financing to Complete Cannabis Cultivation Facility in Maryland
10:16 AM ET, 12/27/2017 - GlobeNewswire
$22.3 million raised by MariMed in 2017 Financing validates MariMed’s ability to fund shareholder-enhancing projects on an as needed basis
NEWTON, Mass. and NEW YORK, Dec. 27, 2017 (GLOBE NEWSWIRE) -- MariMed Inc. (OTCQB:MRMD) has completed a $4 million loan financing through its subsidiary MariMed Advisors with Best Buds Funding LLC. MariMed and its affiliate companies intend to use the proceeds to complete the build out of its medical cannabis cultivation and production facility in Hagerstown, Maryland.
MariMed Inc. is an industry leader in the design, development, operation, funding, and optimization of medical cannabis cultivation, production, and dispensary facilities, and the development and licensing of branded precision dosed cannabis products.
“With this transaction, MariMed has secured debt and equity of approximately $22.348 million this year, proving our ability once again to raise funds in a traditionally very difficult microcap environment coupled with the challenges of the medical cannabis industry,” stated Robert Fireman, CEO of MariMed. “We appreciate Best Bud’s investment and look forward to future transactions supporting our anticipated continued growth and momentum as we expand with facilities and branded products across the U.S.”
Graubard Miller provided legal representation for Best Buds LLC Funding for the transaction.
Search us and post about us on social media with the hash tag #MedicatedByMarimed:Twitter: @MariMedIncFacebook: @MariMedIncInstagram: MariMedIncYouTube: MariMedInc
About MariMed Inc.:MariMed is an industry leader in the development and operation of state licensed regulatory compliant cannabis cultivation, production, and dispensary facilities in multiple states nationwide. These facilities are models of excellence in horticultural principals, cannabis production, product development, and dispensary operations. MariMed is also on the forefront of precision dosed branded products for the treatment of specific medical symptoms. MariMed distributes its branded products in select states and is currently expanding licensing and distribution to numerous additional states encompassing thousands of dispensaries.
MariMed Inc., is one of the 17 top-performing public cannabis companies in the U.S. tracked on the U.S. Marijuana Index, (www.marijuanaindex.com) and CannabIndex. For additional information, visit www.MarimedAdvisors.com
MariMed Contacts:Business DevelopmentJon Levine, CFO, MariMed, Inc.+1 844-244-0200
Recent MRMD News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/11/2024 09:30:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/11/2024 09:05:01 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/07/2024 09:02:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 10:06:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2023 10:03:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/09/2023 09:11:11 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:07:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2023 10:06:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 11:35:02 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/30/2023 09:24:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/30/2023 09:17:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/06/2023 10:29:20 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/04/2023 06:45:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2023 09:13:09 PM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM